188 related articles for article (PubMed ID: 27267386)
21. Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma.
Cain JW; Miljic D; Popovic V; Korbonits M
Expert Rev Endocrinol Metab; 2010 Sep; 5(5):681-695. PubMed ID: 30764022
[TBL] [Abstract][Full Text] [Related]
22. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
23. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
25. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
[TBL] [Abstract][Full Text] [Related]
26. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
Alexander JM; Swearingen B; Tindall GT; Klibanski A
J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
[TBL] [Abstract][Full Text] [Related]
27. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
[TBL] [Abstract][Full Text] [Related]
28. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
[TBL] [Abstract][Full Text] [Related]
29. [Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].
Cai F; Zhang YD; Dai CX; Liu XH; Yang YK; Yao Y; Wang RZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):640-4. PubMed ID: 23286415
[TBL] [Abstract][Full Text] [Related]
30. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
Igreja S; Chahal HS; King P; Bolger GB; Srirangalingam U; Guasti L; Chapple JP; Trivellin G; Gueorguiev M; Guegan K; Stals K; Khoo B; Kumar AV; Ellard S; Grossman AB; Korbonits M;
Hum Mutat; 2010 Aug; 31(8):950-60. PubMed ID: 20506337
[TBL] [Abstract][Full Text] [Related]
31. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
[TBL] [Abstract][Full Text] [Related]
32. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
Beckers A; Daly AF
Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
[TBL] [Abstract][Full Text] [Related]
33. Mild pituitary phenotype in 3- and 12-month-old Aip-deficient male mice.
Lecoq AL; Zizzari P; Hage M; Decourtye L; Adam C; Viengchareun S; Veldhuis JD; Geoffroy V; Lombès M; Tolle V; Guillou A; Karhu A; Kappeler L; Chanson P; Kamenický P
J Endocrinol; 2016 Oct; 231(1):59-69. PubMed ID: 27621108
[TBL] [Abstract][Full Text] [Related]
34. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
35. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
Chahal HS; Chapple JP; Frohman LA; Grossman AB; Korbonits M
Trends Endocrinol Metab; 2010 Jul; 21(7):419-27. PubMed ID: 20570174
[TBL] [Abstract][Full Text] [Related]
36. Rab3B immunoexpression in human pituitary adenomas.
Rotondo F; Scheithauer BW; Kovacs K; Bell DC
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):185-8. PubMed ID: 19384079
[TBL] [Abstract][Full Text] [Related]
37. Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).
Vitali E; Peverelli E; Giardino E; Locatelli M; Lasio GB; Beck-Peccoz P; Spada A; Lania AG; Mantovani G
Mol Cell Endocrinol; 2014 Mar; 383(1-2):193-202. PubMed ID: 24373949
[TBL] [Abstract][Full Text] [Related]
38. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Daly AF; Beckers A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
[TBL] [Abstract][Full Text] [Related]
39. Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners.
Houslay KF; Christian F; MacLeod R; Adams DR; Houslay MD; Baillie GS
Biochem J; 2017 Feb; 474(4):597-609. PubMed ID: 27993970
[TBL] [Abstract][Full Text] [Related]
40. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]